MB, L., FC, F., AS, A., MV, W., FD, F., & SC, F. (2023). Secondary Pharmacological Prevention of Coronary Artery Disease among Patients Submitted to Clinical Management, Percutaneous Coronary Intervention, or Coronary Artery Bypass Graft Surgery. Arquivos brasileiros de cardiologia, 120(2), e20220403. https://doi.org/10.36660/abc.20220403
Chicago Style (17th ed.) CitationMB, Lucca, Fuchs FC, Almeida AS, Wainstein MV, Fuchs FD, and Fuchs SC. "Secondary Pharmacological Prevention of Coronary Artery Disease Among Patients Submitted to Clinical Management, Percutaneous Coronary Intervention, or Coronary Artery Bypass Graft Surgery." Arquivos Brasileiros De Cardiologia 120, no. 2 (2023): e20220403. https://doi.org/10.36660/abc.20220403.
MLA (9th ed.) CitationMB, Lucca, et al. "Secondary Pharmacological Prevention of Coronary Artery Disease Among Patients Submitted to Clinical Management, Percutaneous Coronary Intervention, or Coronary Artery Bypass Graft Surgery." Arquivos Brasileiros De Cardiologia, vol. 120, no. 2, 2023, p. e20220403, https://doi.org/10.36660/abc.20220403.